Retina 2016

Image of Retina 2016 LogoRetina 2016 will take place in the Radisson Blu Royal Hotel on Golden Lane, Dublin 8 ofrom November 10 to 12.  The conference begins on Thursday, November 10 with a number of invite-only events. These include a  workshop on future opportunities in stem cell research; a meeting between Fighting Blindness funded researchers and our Medical and Scientific Advisory Board; and a roundtable discussion on regulatory requirements at all stages of research.

Scientific Programme – Friday, November 11

The Scientific Programme takes place on Friday, November 11, from 9am—6pm. There will also be an early ‘Breakfast with the Prof’ session for young researchers on Friday morning at 8am. The Scientific Programme is designed for clinicians, scientists, policy makers and industry representatives. Retina 2016 speakers include leading scientists and clinicians from the US, Europe and Ireland. Some of the topics to be presented are: identification of mutations that cause inherited retinal conditions, stem cell therapy, advanced ocular imaging, and building 3D mini retinas in lab dishes.  A full programme, including speaker bios and titles, is available at www.Retina.ie. Delegates will be awarded 10 CPD points from the Irish College of Ophthalmologists.

Call for Abstracts!

We are now accepting abstracts for the Retina 2016 Conference. Abstracts may be submitted from basic science or clinical focused research. All abstracts received will be reviewed by our Medical and Scientific Advisory Board and a number will be selected for oral presentation. Abstracts to be considered for oral presentation must be submitted by September 16, 2016. Abstracts submitted after September 16 will only be eligible for poster presentation.

Please click here to register for the Scientific Programme, or to submit your abstract.

Retina 2016 Speakers

  • Prof Austin Roorda: University of California, Berkeley, USA
  • Prof Elfride deBaere: Ghent University, Belgium
  • Prof Frans Cremers: Radboud University Nijmegen Medical Centre, Netherlands
  • Dr Michael Redmond: National Eye Institute, USA
  • Prof Jane Farrar: Trinity College Dublin
  • Prof Robin Ali: University College London
  • Dr David Gamm: University of Wisconsin – Madison, USA
  • Dr Shaomei Wang: Cedars Sinai, Los Angeles, USA
  • Prof Andrew Lotery: University of Southampton, UK
  • Dr Bart Leroy: Ghent University, Belgium

Public Engagement Day– Saturday, November 12

This is the sixth consecutive year that the Retina Conference will include a Public Engagement Day. This day offers a unique opportunity for people affected by sight loss, family members and the general public to engage with leading clinicians and researchers. It provides a platform for Irish patients to learn about their condition and the research that is aiming to find therapies to treat it.

Once again at this year’s conference there will be a number of condition specific break-out sessions. These sessions allow people to share experiences with others who have the same or similar conditions. They also offer the opportunity to direct questions to a panel of experts in a more intimate setting.

Registration is essential!

Attendance at the Public Engagement Day is free for Fighting Blindness members.  For non-members, a nominal fee of €10 will apply on the day. Advance registration is essential for both members and non-members. Please note that registration is limited, you must register for one of the condition specific break-out sessions and state the number of guests, if any, who will be attending with you. As always refreshments will be served on arrival and a hot lunch will be provided for all attendees.

Click here to register for the Retina 2016 Public Engagement Day

Public Engagement Day Programme

10.00am       Registration and Tea/Coffee

10:30am       Welcome & Introduction: Kevin Whelan, Fighting Blindness CEO

11am            Dr David Gamm, University of Wisconsin – Madison

‘Taking the first steps toward a stem cell-based therapy: What keeps researchers awake at night (besides everything)?’

11.20am       Spark Therapeutics: Patient relevant clinical endpoints in clinical trials

11.40am       Prof John Flannery, University of California, Berkeley ‘

‘Overview of On-going Vision Research

12pm            Condition specific breakout sessions

1.15pm         Lunch

2.15pm         Dr Sally Ann Lynch, Consultant Clinical Geneticist Temple Street Children’s Hospital

2.45pm         Caitriona Dunne, Fighting Blindness

3pm              Panel Discussion: ‘Public and Patients Involvement (PPI) in Research and the Importance of Patient Reported Outcomes’

3.50pm         Christina Fasser, President Retina International

4.00pm         Visionaries Choir close Retina 2016

Retina 2016—EXPERT / PIONEERING / CONNECTED

Follow Retina 2016 on Twitter @fightngblindnes #RetinaDublin